IRIDEX CORP (IRIX) Stock Price & Overview
NASDAQ:IRIX • US4626841013
Current stock price
The current stock price of IRIX is 1.04 USD. Today IRIX is down by -3.7%. In the past month the price increased by 5.05%. In the past year, price decreased by -12.6%.
IRIX Key Statistics
- Market Cap
- 18.002M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.26
- Dividend Yield
- N/A
IRIX Stock Performance
IRIX Stock Chart
IRIX Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to IRIX. When comparing the yearly performance of all stocks, IRIX is a bad performer in the overall market: 86.53% of all stocks are doing better.
IRIX Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to IRIX. IRIX has a bad profitability rating. Also its financial health evaluation is rather negative.
IRIX Earnings
On March 26, 2026 IRIX reported an EPS of -0.01 and a revenue of 14.72M. The company beat EPS expectations (50.98% surprise) and missed revenue expectations (-2.07% surprise).
IRIX Forecast & Estimates
7 analysts have analysed IRIX and the average price target is 2.81 USD. This implies a price increase of 169.71% is expected in the next year compared to the current price of 1.04.
For the next year, analysts expect an EPS growth of 52.92% and a revenue growth 1.02% for IRIX
IRIX Groups
Sector & Classification
IRIX Financial Highlights
Over the last trailing twelve months IRIX reported a non-GAAP Earnings per Share(EPS) of -0.26. The EPS increased by 51.85% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -15.22% | ||
| ROE | -90.15% | ||
| Debt/Equity | 0.76 |
IRIX Ownership
IRIX Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 40.01 | 167.282B | ||
| ABT | ABBOTT LABORATORIES | 14.94 | 161.256B | ||
| SYK | STRYKER CORP | 21.26 | 126.004B | ||
| BSX | BOSTON SCIENTIFIC CORP | 14.81 | 89.097B | ||
| EW | EDWARDS LIFESCIENCES CORP | 24.39 | 48.118B | ||
| IDXX | IDEXX LABORATORIES INC | 38.38 | 45.663B | ||
| BDX | BECTON DICKINSON AND CO | 10.95 | 42.774B | ||
| RMD | RESMED INC | 17.69 | 32.344B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.26 | 32.159B | ||
| DXCM | DEXCOM INC | 23.33 | 23.634B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 9.76 | 17.923B | ||
| PODD | INSULET CORP | 28.2 | 13.042B | ||
| PEN | PENUMBRA INC | 63.95 | 12.896B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About IRIX
Company Profile
IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. The company is headquartered in Mountain View, California and currently employs 93 full-time employees. The firm is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Company Info
IPO: 1996-02-16
IRIDEX CORP
1212 Terra Bella Ave
Mountain View CALIFORNIA 94043 US
CEO: David I. Bruce
Employees: 93
Phone: 13026587581
IRIDEX CORP / IRIX FAQ
Can you describe the business of IRIDEX CORP?
IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. The company is headquartered in Mountain View, California and currently employs 93 full-time employees. The firm is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Can you provide the latest stock price for IRIDEX CORP?
The current stock price of IRIX is 1.04 USD. The price decreased by -3.7% in the last trading session.
What is the dividend status of IRIDEX CORP?
IRIX does not pay a dividend.
How is the ChartMill rating for IRIDEX CORP?
IRIX has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Can you provide the growth outlook for IRIDEX CORP?
The Revenue of IRIDEX CORP (IRIX) is expected to grow by 1.02% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is IRIDEX CORP worth?
IRIDEX CORP (IRIX) has a market capitalization of 18.00M USD. This makes IRIX a Nano Cap stock.
Who owns IRIDEX CORP?
You can find the ownership structure of IRIDEX CORP (IRIX) on the Ownership tab.